These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15518422)

  • 1. [Evaluation of the vascular endothelial growth factor in children and adolescents with type 1 diabetes].
    Peczyńska J; Urban M; Urban B; Głowińska B
    Pol Merkur Lekarski; 2004 May; 16(95):438-42. PubMed ID: 15518422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications.
    Chiarelli F; Spagnoli A; Basciani F; Tumini S; Mezzetti A; Cipollone F; Cuccurullo F; Morgese G; Verrotti A
    Diabet Med; 2000 Sep; 17(9):650-6. PubMed ID: 11051284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between vascular endothelial growth factor and hypertension in children and adolescents type I diabetes mellitus.
    Zorena K; Myśliwska J; Myśliwiec M; Rybarczyk-Kapturska K; Malinowska E; Wiśniewski P; Raczyńska K
    J Hum Hypertens; 2010 Nov; 24(11):755-62. PubMed ID: 20164848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
    Peczyńska J; Urban M; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adiponectin as a marker of complications in type I diabetes.
    Habeeb NM; Youssef OI; Saab AA; El Hadidi ES
    Indian Pediatr; 2012 Apr; 49(4):277-80. PubMed ID: 21992860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study of serum insulin-like growth factor-I levels over 6 years in a large cohort of children and adolescents with type 1 diabetes mellitus: A marker reflecting diabetic retinopathy.
    Öberg D; Salemyr J; Örtqvist E; Juul A; Bang P
    Pediatr Diabetes; 2018 Aug; 19(5):972-978. PubMed ID: 29663652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interleukin 12 as an anti-angiogenic mediator in type 1 diabetic children].
    Zorena K; Myśliwska J; Myśliwiec M; Balcerska A; Lipowski P; Raczyńska K
    Pediatr Endocrinol Diabetes Metab; 2007; 13(1):27-31. PubMed ID: 17493403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Selected immunologic and biochemical risk factors of the retinopathy and nephropathy development in children with diabetes mellitus type 1].
    Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Nowacka M; Lipowski P; Raczyńska K
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):269-73. PubMed ID: 17239304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipoprotein (a) in type 1 diabetic children and adolescents: relationships with HbA1c and subclinical complications.
    Willems D; Dorchy H; Dufrasne D
    Eur J Pediatr; 1996 Mar; 155(3):175-8. PubMed ID: 8929723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.
    Hovind P; Tarnow L; Oestergaard PB; Parving HH
    Kidney Int Suppl; 2000 Apr; 75():S56-61. PubMed ID: 10828763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating plasma vascular endothelial growth factor and microvascular complications of type 1 diabetes mellitus: the influence of ACE inhibition.
    Chaturvedi N; Fuller JH; Pokras F; Rottiers R; Papazoglou N; Aiello LP;
    Diabet Med; 2001 Apr; 18(4):288-94. PubMed ID: 11437859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The assessment of the correlation between vascular endothelial growth factor (VEGF), tumor necrosis factor (TNF-alpha), interleukin 6 (IL-6), glycaemic control (HbA1c) and the development of the diabetic retinopathy in children with diabetes mellitus type 1].
    Myśliwiec M; Balcerska A; Zorena K; Myśliwska J; Lipowski P; Raczyńska K
    Klin Oczna; 2007; 109(4-6):150-4. PubMed ID: 17725274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Increased Circulating Plasma Levels of Vascular Endothelial Growth Factor in Patients with Type 1 Diabetes Do Not Correlate to Metabolic Control.
    Singh K; Sandler S; Espes D
    J Diabetes Res; 2017; 2017():6192896. PubMed ID: 28421206
    [No Abstract]   [Full Text] [Related]  

  • 15. Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria.
    Santilli F; Spagnoli A; Mohn A; Tumini S; Verrotti A; Cipollone F; Mezzetti A; Chiarelli F
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3871-6. PubMed ID: 11502826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
    Bonnefond A; Saulnier PJ; Stathopoulou MG; Grarup N; Ndiaye NC; Roussel R; Nezhad MA; Dechaume A; Lantieri O; Hercberg S; Lauritzen T; Balkau B; El-Sayed Moustafa JS; Hansen T; Pedersen O; Froguel P; Charpentier G; Marre M; Hadjadj S; Visvikis-Siest S
    PLoS One; 2013; 8(2):e55921. PubMed ID: 23405237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma vascular endothelial growth factor in Japanese Type 2 diabetic patients with and without nephropathy.
    Shimada K; Baba T; Neugebauer S; Onozaki A; Yamada D; Midorikawa S; Sato W; Watanabe T
    J Diabetes Complications; 2002; 16(6):386-90. PubMed ID: 12477622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Threshold serum concentrations of tumour necrosis factor alpha (TNFα) as a potential marker of the presence of microangiopathy in children and adolescents with type 1 diabetes mellitus (T1DM).
    Zorena K; Kula M; Malinowska E; Raczyńska D; Myśliwiec M; Raczyńska K
    Hum Immunol; 2013 Jan; 74(1):75-81. PubMed ID: 23073299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA
    Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
    BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.